An Innovative Approach for Biomarker Discovery
HAE patient self-sampling for biomarker establishment
Some genetic disorders, including hereditary angioedema (HAE), do not manifest chronically, but by unpredictable attacks. CENTOGENE has developed a protocol for the collection of patient samples during these critical phases. The first clinical study to apply this protocol in a biomarker discovery setting has now been published in the Orphanet Journal of Rare Diseases.